Methemoglobinemia natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.
Overview
Overview
Depending on the causes that have led to methemoglobin formation, different complications and prognosis are expected respectively. Death is the most serious complications of methemoglobinemia especially when MetHb levels approach 70%. In severely sick patients death may occur even with lower levels of MetHb.
Natural History
Natural History
- Patients with hereditary forms of methemoglobinemia are generally asymptomatic, with the exception of having chronic cyanosis. Unfortunately, despite the benign nature of the congenital methemoglobinemia, people with type IIb5 cytochrome-reductase deficiency have poor prognosis and shorter lifespan, mainly due to neurologic complications.
- In acquired methemoglobinemia, depending on the amount and duration of toxin exposure, the levels of MetHb in the blood will be different. As a result we expect different outcomes, which are as follows: MetHb of 15% presents with skin and blood color changes at levels; levels above 15% will result in hypoxia and levels above 70% can lead to death. [1] [2]
Complications
Complications
Prognosis
Prognosis
- Depending on the anoxic end-organ damage caused by MetHb, the prognosiss varies between mild and fatal. [1]
References
References
- ↑ 1.0 1.1 do Nascimento TS, Pereira RO, de Mello HL, Costa J (2008). “Methemoglobinemia: from diagnosis to treatment”. Rev Bras Anestesiol. 58 (6): 651–64. PMID 19082413.
- ↑ 2.0 2.1 Bradberry SM (2003). “Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue”. Toxicol Rev. 22 (1): 13–27. PMID 14579544.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
